Blood marker can identify risk of silent disability progression in MSPublished: 15 February 2022 The levels of a protein called glial fibrillary acidic protein (GFAP) in the blood of people with multiple sclerosis (MS) can help to predict disability that happens in the absence of relapses – often called silent